Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DP001 in Postmenopausal Women With Osteopenia
NCT00715676Phase 2Completed
- Sponsor
- Deltanoid Pharmaceuticals
- Start
- Mar 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DP-001 in osteopenia, sponsored by Deltanoid Pharmaceuticals. Started Mar 2007; status: completed.
02
Drugs
DP-001
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT00715676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00715676.